Join our mailing list!






You are here: Home > Pharmacy > Webcasts
Sort By:
Page of 1
pharmacy coding
2012 Pharmacy Coding & Billing Combo
Our Price: $336.00
Sale Price: $235.00
You save $101.00!

SPECIAL PACKAGE OFFER...SAVE $101!

Dozens of new, revised and discontinued codes will take effect in 2012. If you dont know what they are, you wont assign the correct codes or submit clean claims. Its that simple.
2012 Pharmacy Drug Coding and Billing Strategies
Our Price: $199.00

Available Now!

For 2012 your staff will need to learn dozens of changes to pharmacy HCPCS codes and how to make the correct code assignments. But thats just one facet of the big changes you will encounter when January 1 arrives.
2011 Hospital Pharmacy Vulnerabilities: Pricing Trends and Pitfalls
Our Price: $199.00

Available Now!

How to correctly establish prices for drugs in the formulary is one of a hospitals biggest challenges. And every year brings changes and new twists to make the decision process that much more difficult.
2011 Hospital Pharmacy Vulnerabilities: 340B Program Compliance
Our Price: $199.00

Available Now!

Thanks to expansion of the 340B Drug Pricing Program, many more hospitals are procuring drugs at substantially reduced costs. But problems may arise
2011 Hospital Pharmacy Vulnerabilities: Matching Drug to Administration Charges
Our Price: $199.00

Available Now!

MedLearn consulting experts have documented a recurring problem: a disconnect between charges for drugs and charges for the injection or infusion of those drugs
2011 Hospital Pharmacy Vulnerability Series
Our Price: $796.00
Sale Price: $637.00
You save $159.00!

SPECIAL PACKAGE OFFER...SAVE 20%

Join us during 2011 for a four-part series of MedLearn webcasts that address potential vulnerabilities in your pharmacy's coding, billing and compliance practices.
2011 Hospital Pharmacy Vulnerabilities: Medicare Coverage Restrictions
Our Price: $199.00

Available Now!

The 2011 Medicare program is laden with new coverage restrictions - fueled in large part by the expansion of local coverage determinations (LCDs) for drugs and biologicals.